Loading…

OK to use analytics cookies? We measure usage without cookies either way; accepting lets us see repeat visits. Declining changes nothing about how the site works. Privacy policy

Pricing About us Log in Create a free account

Directory

Every key opinion leader in the directory, every fact cited to its public source.

Showing 25–30 of 30 KOLs

Sort

Drug: Canakinumab✕

Roy Herbst, MD, PhD

Basic profileOncologyMedical OncologySouth Central · TX

—
publications: —
h-index: 8
trials

View profile →

John Davis, MD

Basic profileRheumatology/ImmunologyRheumatologyMidwest · MN

—
publications: —
h-index: 3
trials

View profile →

Robert Monger, MD

Basic profileRheumatology/ImmunologyRheumatologyWest · WY

—
publications: —
h-index

View profile →

Peter Enzinger, MD

Dana-Farber Cancer Institute

Enriched profileGastrointestinalMedical OncologyNortheast · MA

—
publications: 65
h-index: 11
trials

View profile →

John Cush, MD

TCU Burnett School of Medicine

Enriched profileRheumatology/ImmunologyRheumatologySouth Central · TX

—
publications: 41
h-index: 1
trial

View profile →

John Stone, MD

Massachusetts General Hospital

Enriched profileRheumatology/ImmunologyRheumatologyNortheast · MA

—
publications: 15
h-index: 8
trials

View profile →

← PrevPage 2 of 2Next →

findmyKOL

The world’s largest open source directory of pharma KOLs.

KOLs by therapeutic area

Oncology
Respiratory
Cardiology
Infectious Disease
Neurology
Rare/Genetic
Gastroenterology
Psychiatry
Endocrinology/Metabolic
Rheumatology/Immunology
Nephrology
Ophthalmology
Dermatology
Hematology
Epidemiology
All therapeutic areas →

KOLs by region

Northeast
West
Southeast
Midwest
South Central
All regions →

About

Directory
Institutions
Companies
About us
Blog
Pricing
Methodology
Sources
How we verify
Contact

© 2026 findmyKOL